Hematopoietic Stem Cell Deficiencies in Mice Lacking C-Mpl, the Receptor for Thrombopoietin

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1998 Mar 14

PMID 9448308

Citations 146

Authors

S Kimura

A W Roberts

D Metcalf

W S Alexander

Affiliations

Soon will be listed here.

Abstract

Thrombopoietin (TPO) acts as a lineage-specific late-acting factor to stimulate megakaryocyte and platelet formation. However, analysis of mice lacking either the cytokine or its receptor, c-Mpl, also revealed deficiencies in progenitor cells of multiple hematopoietic lineages, suggesting that TPO signaling may play an important role in the regulation of the hematopoietic stem cell compartment. To investigate this hypothesis, we determined preprogenitor and colony forming unit-spleen (CFU-S) numbers and analyzed the long-term hematopoietic repopulating capacity of bone marrow cells from mpl-/- mice. mpl-/- mice had 4- to 12-fold fewer preprogenitor cells than wild-type mice. In irradiated normal recipients, mpl-/- bone marrow generated 8- to 10-fold fewer spleen colonies than wild-type marrow at both 8 and 12 days after transplantation. This defect was intrinsic to the transplanted hematopoietic cells, as the microenvironment of mpl-/- recipients supported similar CFU-S growth to that observed in wild-type recipients. In definitive assays of stem cell function, bone marrow cells from mpl-/- mice failed to compete effectively with normal cells for long-term reconstitution of the hematopoietic organs of irradiated recipients, even when transplanted in 10-fold excess. Serial transplantation studies further suggested that stem cell self-renewal also may be compromised in mpl-/- mice. These data imply that TPO, signaling through c-Mpl, plays a vital physiological role in the regulation of hematopoietic stem cell production and function.

Citing Articles

TET2 deficiency increases the competitive advantage of hematopoietic stem and progenitor cells through upregulation of thrombopoietin receptor signaling.

Yang Y, Cathelin S, Liu A, Subedi A, Maher A, Hosseini M Nat Commun. 2025; 16(1):2384.

PMID: 40064887 PMC: 11894142. DOI: 10.1038/s41467-025-57614-y.

G2 arrest primes hematopoietic stem cells for megakaryopoiesis.

Garyn C, Bover O, Murray J, Ma J, Salas-Briceno K, Ross S Cell Rep. 2024; 43(7):114388.

PMID: 38935497 PMC: 11330628. DOI: 10.1016/j.celrep.2024.114388.

Understanding megakaryocyte phenotypes and the impact on platelet biogenesis.

Chen S, Looney M Transfusion. 2024; 64(7):1372-1380.

PMID: 38923572 PMC: 11251837. DOI: 10.1111/trf.17927.

Megakaryocytic IGF1 coordinates activation and ferroptosis to safeguard hematopoietic stem cell regeneration after radiation injury.

Liao W, Chen X, Zhang S, Chen J, Liu C, Yu K Cell Commun Signal. 2024; 22(1):292.

PMID: 38802843 PMC: 11129484. DOI: 10.1186/s12964-024-01651-5.

Differential in vivo roles of Mpl cytoplasmic tyrosine residues in murine hematopoiesis and myeloproliferative disease.

Behrens K, Kauppi M, Viney E, Kueh A, Hyland C, Willson T Leukemia. 2024; 38(6):1342-1352.

PMID: 38491305 PMC: 11147766. DOI: 10.1038/s41375-024-02219-5.

References

Wendling F, Varlet P, Charon M, Tambourin P . MPLV: a retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology. 1986; 149(2):242-6. DOI: 10.1016/0042-6822(86)90125-x. View

Hunt P, Li Y, Nichol J, Hokom M, Bogenberger J, Swift S . Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood. 1995; 86(2):540-7. View

Harrison D, Astle C . Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure. J Exp Med. 1982; 156(6):1767-79. PMC: 2186863. DOI: 10.1084/jem.156.6.1767. View

Lok S, Kaushansky K, Holly R, Kuijper J, Oort P, Grant F . Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 1994; 369(6481):565-8. DOI: 10.1038/369565a0. View

Tanimukai S, Kimura T, SAKABE H, Ohmizono Y, Kato T, Miyazaki H . Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Exp Hematol. 1997; 25(10):1025-33. View

Berardi A, Wang A, Levine J, Lopez P, Scadden D . Functional isolation and characterization of human hematopoietic stem cells. Science. 1995; 267(5194):104-8. DOI: 10.1126/science.7528940. View

Borge O, Ramsfjell V, Cui L, Jacobsen S . Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood. 1997; 90(6):2282-92. View

Mackarehtschian K, Hardin J, Moore K, Boast S, Goff S, Lemischka I . Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity. 1995; 3(1):147-61. DOI: 10.1016/1074-7613(95)90167-1. View

Harrison D . Competitive repopulation: a new assay for long-term stem cell functional capacity. Blood. 1980; 55(1):77-81. View

10.

Lamar E, Palmer E . Y-encoded, species-specific DNA in mice: evidence that the Y chromosome exists in two polymorphic forms in inbred strains. Cell. 1984; 37(1):171-7. DOI: 10.1016/0092-8674(84)90312-x. View

11.

Grossmann A, Lenox J, Ren H, HUMES J, Forstrom J, Kaushansky K . Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice. Exp Hematol. 1996; 24(10):1238-46. View

12.

Metcalf D . Lineage commitment of hemopoietic progenitor cells in developing blast cell colonies: influence of colony-stimulating factors. Proc Natl Acad Sci U S A. 1991; 88(24):11310-4. PMC: 53124. DOI: 10.1073/pnas.88.24.11310. View

13.

Kaushansky K, Lok S, Holly R, Broudy V, Lin N, BAILEY M . Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994; 369(6481):568-71. DOI: 10.1038/369568a0. View

14.

Gurney A, de Sauvage F, Moore M . Thrombocytopenia in c-mpl-deficient mice. Science. 1994; 265(5177):1445-7. DOI: 10.1126/science.8073287. View

15.

Ogawa M . Differentiation and proliferation of hematopoietic stem cells. Blood. 1993; 81(11):2844-53. View

16.

de Sauvage F, Luoh S, Ryan A, Dowd M, Eaton D, Moore M . Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 1996; 183(2):651-6. PMC: 2192470. DOI: 10.1084/jem.183.2.651. View

17.

Kobayashi M, Laver J, Kato T, Miyazaki H, Ogawa M . Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood. 1996; 88(2):429-36. View

18.

RUSSELL E . Hereditary anemias of the mouse: a review for geneticists. Adv Genet. 1979; 20:357-459. View

19.

Metcalf D . Murine hematopoietic stem cells committed to macrophage/dendritic cell formation: stimulation by Flk2-ligand with enhancement by regulators using the gp130 receptor chain. Proc Natl Acad Sci U S A. 1997; 94(21):11552-6. PMC: 23534. DOI: 10.1073/pnas.94.21.11552. View

20.

Bernad A, Kopf M, Kulbacki R, Weich N, Koehler G, Gutierrez-Ramos J . Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity. 1994; 1(9):725-31. DOI: 10.1016/s1074-7613(94)80014-6. View